ABVC BioPharma, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $8.8M | $5.8M |
| FY2022 | — | $3.1M | $85.3K |
| FY2023 | — | $1.6M | $60.2K |
| FY2024 | — | $1.2M | $248.4K |
| FY2025 | — | $11.1M | $681.5K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $8.8M | $5.8M |
| FY2022 | — | $3.1M | $85.3K |
| FY2023 | — | $1.6M | $60.2K |
| FY2024 | — | $1.2M | $248.4K |
| FY2025 | — | $11.1M | $681.5K |